States / Washington / SB 5240
SB 5240 Floor Consideration
Concerning anaphylaxis medications in schools.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Mar 12, 2026 · House
By resolution, returned to Senate Rules Committee for third reading.
Mar 4, 2026 · House
Rules Committee relieved of further consideration. Placed on second reading.
Feb 25, 2026 · House
Referred to Rules 2 Review.
Feb 23, 2026 · House
Executive action taken in the House Committee on Education at 1:30 PM.
Feb 23, 2026 · House
ED - Majority; do pass with amendment(s).
Feb 18, 2026 · House
Public hearing in the House Committee on Education at 10:30 AM.
Jan 26, 2026 · House
First reading, referred to Education.
Jan 21, 2026 · Senate
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
Jan 13, 2026 · Senate
Placed on third reading by Rules Committee.
Jan 12, 2026 · Senate
By resolution, reintroduced and retained in present status.
Apr 27, 2025 · House
By resolution, returned to Senate Rules Committee for third reading.
Mar 18, 2025 · House
Public hearing in the House Committee on Education at 4:00 PM.
Mar 12, 2025 · House
First reading, referred to Education.
Mar 10, 2025 · Senate
1st substitute bill substituted (EDU 25).
Mar 10, 2025 · Senate
Rules suspended. Placed on Third Reading.
Mar 10, 2025 · Senate
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
Mar 5, 2025 · Senate
Placed on second reading by Rules Committee.
Feb 12, 2025 · Senate
Passed to Rules Committee for second reading.
Feb 11, 2025 · Senate
Executive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM.
Feb 11, 2025 · Senate
EDU - Majority; 1st substitute bill be substituted, do pass.
Jan 29, 2025 · Senate
Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM.
Jan 14, 2025 · Senate
First reading, referred to Early Learning & K-12 Education.